NeuRizer Ltd.

As of June 30, 2024, NeuRizer Ltd. has 1.90B shares outstanding.

These figures are as of June 30, 2024.

These figures are as of June 30, 2024. NeuRizer Ltd. trades at an EV/FCF ratio of 8.71, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of June 30, 2024, NeuRizer Ltd. maintains a current ratio of 0.01, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.89, indicating elevated leverage, while an interest coverage ratio of -0.93 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2024, NeuRizer Ltd. posted a negative return on equity (ROE) of -7.69, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -4.34, reflecting losses generated across the asset base.

These figures cover the twelve months ended June 30, 2024. Total shareholder yield is negative at -8.45, meaning NeuRizer Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

NeuRizer Ltd.'s most recent stock split took place on February 18, 2011 with a 125:129 split ratio.

As of June 30, 2024, NeuRizer Ltd. has an Altman Z-Score of -1.47, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.